Article
Circulating Inhibitory Factor 1 levels in adult patients with Prader-Willi syndrome.
Hormone molecular biology and clinical investigation - 5 Mar 2021
Delvecchio Maurizio, Grugni Graziano, Mai Stefania, Favoino Elvira, Ingletto Annalisa, Gnoni Antonio
Abstract excerpt
OBJECTIVES: Prader-Willi syndrome (PWS) is a rare genetic syndrome characterized by hyperphagia and early development of morbid obesity. Cardiovascular disease (CVD) and metabolic syndrome (MetS) are major comorbidities in these patients leading to premature death. Inhibitory factor 1 (IF1) works as a regulatory protein, inhibiting the ATP hydrolase activity of mitochondrial ATP synthase and likely playing a role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.